drugset

drugset / Trial / NCT00335712

Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus

NCT00335712 ↗

Phase 2 Completed 81 enrolled Ono Pharma USA Inc

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of ONO-5129 in patients with type 2 diabetes mellitus.

Timeline

Start: 2006-06
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ONO-5129	Unknown	—	—

Indications